Anderson MJ, Jones SE, Fisher-Hoch SP.
et al. Human parvovirus, the cause of erythema infectiosum (fifth
disease)? [letter]. Lancet.1983;1:1378.
Brown KE, Young NS. Parvovirus B19 in human disease. Annu Rev Med.1997;48:59-67.
Cohen B. Parvovirus B19: an expanding spectrum of
disease. BMJ.1995;311:1549-1552.
Brown T, Anand A, Ritchie LD, Clewley JP, Reid TMS. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet.1984;2:1033-1034.
Public Health Laboratory Service Working
Party on Fifth Disease. Prospective study of human parvovirus (B19)
infection in pregnancy. BMJ.1990;300:1166-1170.
Torok TJ. Parvovirus B19 and human disease. Adv
Intern Med.1992;37:431-455.
Cohen BJ, Hall SM, Healing TD, Morse DL, Owen RJ. Quarterly communicable disease review January to March 1993: from the
PHLS Communicable Disease Surveillance Centre. J Public Health
Med.1993;15:281-288.
Woolf AD, Campion GV, Chishick A.
et al. Clinical
manifestations of human parvovirus B19 in adults. Arch Intern
Med.1989;149:1153-1156.
Rice PS, Cohen BJ. A school outbreak of parvovirus B19
infection investigated using salivary antibody assays. Epidemiol
Infect.1996;116:331-338.
Chorba T, Coccia P, Holman RC.
et al. The role of
parvovirus B19 in aplastic crisis and erythema infectiosum (fifth
disease). J Infect Dis.1986;154:383-393.
Gillespie SM, Cartter ML, Asch S.
et al. Occupational
risk of human parvovirus B19 infection for school and day-care
personnel during an outbreak of erythema infectiosum. JAMA.1990;263:2061-2065.
Cartter ML, Farley TA, Rosengren S.
et al. Occupational risk factors for infection with parvovirus B19 among
pregnant women. J Infect Dis.1991;163:282-285.
Westergaard T, Andersen PK, Pedersen JB.
et al. Birth
characteristics, sibling patterns, and acute leukemia risk in
childhood: a population-based cohort study. J Natl Cancer
Inst.1997;89:939-947.
Statistics Denmark. Statistics on Persons: A
Register-Based Statistical System. Copenhagen, Denmark: Statistics
Denmark; 1995.
Melbye M, Wohlfart J, Olsen JH.
et al. Induced abortion
and the risk of breast cancer. N Engl J Med.1997;336:81-85.
Knudsen LB, Kristensen FB. Monitoring perinatal
mortality and perinatal care with a national register: content and
usage of the Danish Medical Birth Register. Community Med.1986;8:29-36.
Becker NG, Melbye M. Use of a log-linear model to
compute the empirical survival curve from interval-censored data, with
application to data on HIV tests for HIV positivity. Aust J
Stat.1991;33:125-133.
Carstensen B. Regression models for interval censored
survival data: application to HIV infection in Danish homosexual men. Stat Med.1996;15:2177-2189.
Agresti A. Categorical Data Analysis. New
York, NY: John Wiley & Sons Inc; 1990.
SAS Institute Inc. The GENMOD procedure. In:
SAS/STAT Software: Changes and Enhancements for Release 6.12. Cary, NC: SAS Institute Inc; 1996:21-42.
Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors
using case-control data. Am J Epidemiol.1985;122:904-914.
Anderson LJ, Tsou C, Parker RA.
et al. Detection of
antibodies and antigens of human parvovirus B19 by enzyme-linked
immunosorbent assay. J Clin Microbiol.1986;24:522-526.
Eis-Hubinger AM, Oldenburg J, Brackmann HH, Matz B, Schneweis KE. The prevalence of antibody to parvovirus B19 in
hemophiliacs and in the general population. Zentralbl
Bakteriol.1996;284:232-240.
Cohen BJ, Buckley MM. The prevalence of antibody to
human parvovirus B19 in England and Wales. J Med Microbiol.1988;25:151-153.
Pillay D, Patou G, Hurt S, Kibbler CC, Griffiths PD. Parvovirus B19 outbreak in a children's ward. Lancet.1992;339:107-109.
Bell LM, Naides SJ, Stoffman P, Hodinka RL, Plotkin SA. Human parvovirus B19 infection among hospital staff members after
contact with infected patients. N Engl J Med.1989;321:485-491.
Azzi A, Trotta M, Zakrzewska K.
et al. Human parvovirus
B19 infection within a family and risk for pregnant women. Epidemiol Infect.1996;117:401-403.
Harger JH, Adler SP, Koch WC, Harger GF. Prospective
evaluation of 618 pregnant women exposed to parvovirus B19: risks and
symptoms. Obstet Gynecol.1998;91:413-420.
Koch WC, Adler SP. Human parvovirus B19 infections in
women of childbearing age and within families. Pediatr Infect Dis J.1989;8:83-87.
Gratacos E, Torres P, Vidal J.
et al. The incidence of
human parvovirus B19 infection during pregnancy and its impact on
perinatal outcome. J Infect Dis.1995;171:1360-1363.
Skjoldebrand-Sparre L, Fridell E, Nyman M, Wahren B. A
prospective study of antibodies against parvovirus B19 in pregnancy. Acta Obstet Gynecol Scand.1996;75:336-339.
Rodis JF, Quinn DL, Gary GWJ.
et al. Management and
outcomes of pregnancies complicated by human B19 parvovirus infection:
a prospective study. Am J Obstet Gynecol.1990;163:1168-1171.